SAFETY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A CANDIDATE VACCINE IN HEALTHY ADULT VOLUNTEERS

被引:78
|
作者
WIEDERMANN, G
AMBROSCH, F
KOLLARITSCH, H
HOFMANN, H
KUNZ, C
DHONDT, E
DELEM, A
ANDRE, FE
SAFARY, A
STEPHENNE, J
机构
[1] UNIV VIENNA,INST VIROL,A-1010 VIENNA,AUSTRIA
[2] SMITH KLINE BIOL,RIXENSART,BELGIUM
关键词
Candidate vaccine; ELISA; hepatitis A; inactivated;
D O I
10.1016/0264-410X(90)90013-C
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The reactogenicity and immunogenicity of a formaldehyde-inactivated hepatitis A vaccine have been investigated. Three different dose levels of vaccine (180, 360 and 720 ELISA units) were administered to healthy volunteers according to a 0, 1, 2 and 12 month schedule. The vaccine was safe and well tolerated. Reactions observed following vaccination were essentially mild and were not dependent upon the quantity of antigen administered. All subjects had measurable titres of anti-HAV antibodies after the full vaccination course; the immune response to the vaccine was dose-related. Antibody titres in vaccinees at month 13 were between 60- and 190-fold higher than those observed in a group of subjects given anti-HAV immunoglobulin. © 1990.
引用
收藏
页码:581 / 584
页数:4
相关论文
共 50 条
  • [31] INACTIVATED CANDIDATE VACCINES FOR HEPATITIS-A
    ANDRE, FE
    HEPBURN, A
    DHONDT, E
    [J]. PROGRESS IN MEDICAL VIROLOGY, 1990, 37 : 72 - 95
  • [32] IMMUNOGENICITY OF INACTIVATED HEPATITIS-A VIRAL VACCINE OF CELL-CULTURE ORIGIN
    KUSOV, YY
    ELBERT, LB
    KAZACHKOV, YA
    VALYANO, NM
    NELGA, IV
    GRISHINA, GK
    KRUTYANSKAYA, GL
    LISITSYNA, EA
    POLESHCHUK, VF
    SOBOL, AV
    TITOVA, IP
    KARPOVICH, LG
    KALASHNIKOVA, TV
    BALAYAN, MS
    [J]. VOPROSY VIRUSOLOGII, 1991, 36 (03) : 206 - 209
  • [33] Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine
    Dagan, R
    Greenberg, D
    Goldenbertg-Gehtman, P
    Vidor, E
    Briantais, P
    Pinsk, V
    Athias, O
    Dumas, R
    [J]. VACCINE, 1999, 17 (15-16) : 1919 - 1925
  • [34] REACTOGENICITY AND IMMUNOGENICITY OF INACTIVATED HEPATITIS-A VACCINES
    JUST, M
    BERGER, R
    [J]. VACCINE, 1992, 10 : S110 - S113
  • [35] IMMUNOGENICITY, SAFETY AND TOLERABILITY OF VARYING DOSES AND REGIMENS OF INACTIVATED HEPATITIS-A VIRUS-VACCINE IN NAVAJO CHILDREN
    NEWCOMER, W
    RIVIN, B
    REID, R
    MOULTON, LH
    WOLFF, M
    CROLL, J
    JOHNSON, C
    BROWN, L
    NALIN, D
    SANTOSHAM, M
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (07) : 640 - 642
  • [36] INACTIVATED VIROSOME HEPATITIS-A VACCINE
    LOUTAN, L
    BOVIER, P
    ALTHAUS, B
    GLUCK, R
    [J]. LANCET, 1994, 343 (8893): : 322 - 324
  • [37] INACTIVATED VIROSOME HEPATITIS-A VACCINE
    DHONDT, E
    DELEM, A
    [J]. LANCET, 1994, 343 (8906): : 1165 - 1166
  • [38] SAFETY, TOLERABILITY AND IMMUNOGENICITY OF A FORMALIN-INACTIVATED HEPATITIS-A VACCINE (VAQTA(R)) IN RURAL KENTUCKY CHILDREN
    BLOCK, SL
    HEDRICK, JA
    TYLER, RD
    SMITH, RA
    CALANDRA, G
    PATTERSON, C
    LEWIS, J
    SITRIN, R
    MILLER, W
    SCHWARTZ, S
    WIENS, B
    NALIN, D
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (12) : 976 - 980
  • [39] SAFETY AND EFFECTIVENESS OF THE NEW INACTIVATED HEPATITIS-A VIRUS-VACCINE
    FURESZ, J
    SCHEIFELE, DW
    PALKONYAY, L
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1995, 152 (03) : 343 - 348
  • [40] Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers
    McNeil, SA
    Halperin, SA
    Langley, JM
    Smith, B
    Warren, A
    Sharratt, GP
    Baxendale, DM
    Reddish, MA
    Hu, MC
    Stroop, SD
    Linden, J
    Fries, LF
    Vink, PE
    Dale, JB
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (08) : 1114 - 1122